no longer losing weight on tirzepatide GLP-1 Weightloss Why Tirzepatide Isn't Working: 2026
Description
Mounjaro has received FDA Fast Track designation to speed up its path for FDA submission for treating adults with obesity, or overweight with weight-related health conditions.In the SURMOUNT-1 clinical trial the average weight loss after 72 weeks was 15% for the 5mg dose, 19.5% for the 10mg dose and 20.9% for the 15mg dose.Mounjaro isnotFDA approved as a weight loss medication.Important information:Mounjaro may cause thyroid C-cell tumors
Shapely offers Contrave, a doctor-prescribed weight loss pill
90
There is a greater emphasis on weight management as part of the holistic approach to diabetes management
